Press Releases

A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan Kettering Cancer Center in New York and Lund University in Sweden.

The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either <I>BRCA1</I> or <I>BRCA2</I> mutations. A new multicenter study led by researchers at Memorial Sloan Kettering Cancer Center is the first prospective examination of the impact of this procedure in which <I>BRCA2</I> mutation carriers were analyzed separately from <I>BRCA1</I> mutation carriers.

A $10 million commitment from James H. and Marilyn H. Simons through the Simons Foundation will support preclinical initiatives undertaken as part of Memorial Sloan Kettering's new Brain Tumor Center (BTC).

Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis.

Breast cancer risk varies widely among women who are carriers of the <i>BRCA1</i> and <i>BRCA2</i> mutations, according to a new study published in the January 9, 2008, issue of the <i>Journal of the American Medical Association</i> (JAMA).

A new study by researchers at Memorial Sloan Kettering Cancer Center finds that even the sickest cancer patients are willing and able to "self-report" symptoms using the Internet, thus supplying key data in real time to their healthcare providers.

According to a new study published online today in the <I>Journal of the National Cancer Institute</I>, prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by surgeons with less experience.

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.